BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,486,000 | -36.2% | 1,500,000 | -35.3% | 1.26% | -14.5% |
| Q1 2022 | $2,330,000 | -4.6% | 2,320,000 | 0.0% | 1.47% | -7.8% |
| Q4 2021 | $2,442,000 | +2.0% | 2,320,000 | 0.0% | 1.59% | +11.6% |
| Q3 2021 | $2,395,000 | -18.5% | 2,320,000 | -17.7% | 1.43% | +6.7% |
| Q2 2021 | $2,938,000 | +1.5% | 2,820,000 | 0.0% | 1.34% | -27.1% |
| Q1 2021 | $2,895,000 | -16.1% | 2,820,000 | -12.4% | 1.84% | +5.1% |
| Q4 2020 | $3,452,000 | +2.5% | 3,220,000 | 0.0% | 1.75% | +5.0% |
| Q3 2020 | $3,368,000 | +10.8% | 3,220,000 | +30.4% | 1.66% | -19.0% |
| Q2 2020 | $3,040,000 | +18.0% | 2,470,000 | 0.0% | 2.05% | -22.6% |
| Q1 2020 | $2,576,000 | -24.6% | 2,470,000 | -23.3% | 2.65% | +28.2% |
| Q4 2019 | $3,416,000 | +7.6% | 3,220,000 | 0.0% | 2.07% | +3.3% |
| Q3 2019 | $3,176,000 | +19.6% | 3,220,000 | +26.3% | 2.00% | +4.0% |
| Q2 2019 | $2,656,000 | +1.1% | 2,550,000 | 0.0% | 1.93% | -21.5% |
| Q1 2019 | $2,626,000 | -12.1% | 2,550,000 | -15.0% | 2.46% | -13.0% |
| Q4 2018 | $2,986,000 | -6.1% | 3,000,000 | 0.0% | 2.82% | +49.4% |
| Q3 2018 | $3,179,000 | +4.2% | 3,000,000 | 0.0% | 1.89% | -13.1% |
| Q2 2018 | $3,050,000 | – | 3,000,000 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |